Literature DB >> 35134344

Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity.

Preetish Kadur Lakshminarasimha Murthy1, Rui Xi2, Diana Arguijo3, Jeffrey I Everitt4, Dewran D Kocak2, Yoshihiko Kobayashi5, Aline Bozec6, Silvestre Vicent7, Shengli Ding8, Gregory E Crawford9, David Hsu10, Purushothama Rao Tata11, Timothy Reddy12, Xiling Shen13.   

Abstract

Oncogenic Kras induces a hyper-proliferative state that permits cells to progress to neoplasms in diverse epithelial tissues. Depending on the cell of origin, this also involves lineage transformation. Although a multitude of downstream factors have been implicated in these processes, the precise chronology of molecular events controlling them remains elusive. Using mouse models, primary human tissues, and cell lines, we show that, in Kras-mutant alveolar type II cells (AEC2), FOSL1-based AP-1 factor guides the mSWI/SNF complex to increase chromatin accessibility at genomic loci controlling the expression of genes necessary for neoplastic transformation. We identified two orthogonal processes in Kras-mutant distal airway club cells. The first promoted their transdifferentiation into an AEC2-like state through NKX2.1, and the second controlled oncogenic transformation through the AP-1 complex. Our results suggest that neoplasms retain an epigenetic memory of their cell of origin through cell-type-specific transcription factors. Our analysis showed that a cross-tissue-conserved AP-1-dependent chromatin remodeling program regulates carcinogenesis.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATAC-seq; Fosl1; KRAS; NSCLC; adenocarcinoma; alveolar type II cell; club cell; epigenetics; intestinal stem cell; lung

Mesh:

Substances:

Year:  2022        PMID: 35134344      PMCID: PMC8938988          DOI: 10.1016/j.devcel.2022.01.006

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   13.417


  117 in total

1.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets.

Authors:  Evan Z Macosko; Anindita Basu; Rahul Satija; James Nemesh; Karthik Shekhar; Melissa Goldman; Itay Tirosh; Allison R Bialas; Nolan Kamitaki; Emily M Martersteck; John J Trombetta; David A Weitz; Joshua R Sanes; Alex K Shalek; Aviv Regev; Steven A McCarroll
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

2.  The landscape of accessible chromatin in mammalian preimplantation embryos.

Authors:  Jingyi Wu; Bo Huang; He Chen; Qiangzong Yin; Yang Liu; Yunlong Xiang; Bingjie Zhang; Bofeng Liu; Qiujun Wang; Weikun Xia; Wenzhi Li; Yuanyuan Li; Jing Ma; Xu Peng; Hui Zheng; Jia Ming; Wenhao Zhang; Jing Zhang; Geng Tian; Feng Xu; Zai Chang; Jie Na; Xuerui Yang; Wei Xie
Journal:  Nature       Date:  2016-06-15       Impact factor: 49.962

Review 3.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

4.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

5.  Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.

Authors:  Christopher J Sarkisian; Blaine A Keister; Douglas B Stairs; Robert B Boxer; Susan E Moody; Lewis A Chodosh
Journal:  Nat Cell Biol       Date:  2007-04-22       Impact factor: 28.824

6.  Crypt stem cells as the cells-of-origin of intestinal cancer.

Authors:  Nick Barker; Rachel A Ridgway; Johan H van Es; Marc van de Wetering; Harry Begthel; Maaike van den Born; Esther Danenberg; Alan R Clarke; Owen J Sansom; Hans Clevers
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

7.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.

Authors:  Patty Trobridge; Sue Knoblaugh; M Kay Washington; Nina M Munoz; Karen D Tsuchiya; Andres Rojas; Xiaoling Song; Cornelia M Ulrich; Takehiko Sasazuki; Senji Shirasawa; William M Grady
Journal:  Gastroenterology       Date:  2009-02-04       Impact factor: 22.682

8.  Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Andrew E Teschendorff; Kelly A Holmes; H Raza Ali; Mark J Dunning; Gordon D Brown; Ondrej Gojis; Ian O Ellis; Andrew R Green; Simak Ali; Suet-Feung Chin; Carlo Palmieri; Carlos Caldas; Jason S Carroll
Journal:  Nature       Date:  2012-01-04       Impact factor: 49.962

9.  The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2.

Authors:  Xia Xu; Lingling Huang; Christopher Futtner; Brian Schwab; Rishi R Rampersad; Yun Lu; Thomas A Sporn; Brigid L M Hogan; Mark W Onaitis
Journal:  Genes Dev       Date:  2014-09-01       Impact factor: 11.361

10.  SENP3-mediated host defense response contains HBV replication and restores protein synthesis.

Authors:  Rui Xi; Preetish Kadur Lakshminarasimha Murthy; Kuei-Ling Tung; Cynthia D Guy; Ji Wan; Feng Li; Zhuo Wang; Xiaodong Li; Anastasia Varanko; Nikolai Rakhilin; Yongning Xin; Botao Liu; Shu-Bing Qian; Lishan Su; Yan Han; Xiling Shen
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.